Indonesia, Thailand, Vietnam Testing H1N1 Alternative Drug
This article was originally published in PharmAsia News
Indonesia, Thailand and Vietnam have become central locations for testing alternative medicines for the H1N1 virus because an increasing number of patients have become resistant to existing treatments. In all three countries, clinical trials have begun on peramivir as an alternative antiviral to Roche's Tamiflu (oseltamivir), the main treatment against the virus, but reportedly facing resistant strains of the flu that are developing as a result to overuse. The seasonal flu virus also is reported becoming resistant to Tamiflu. (Click here for more
You may also be interested in...
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.